Cytosorbents Crp
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $9,633 | $8,864 | $9,234 | $9,485 |
Gross Profit | 7,049 | 6,130 | 6,804 | 6,666 |
EBITDA | -3,349 | -3,896 | -4,366 | -2,525 |
EBIT | -3,549 | -4,272 | -4,751 | -2,926 |
Net Income | -4,417 | -5,129 | -5,497 | -3,170 |
Net Change In Cash | 9,633 | 8,864 | 9,234 | 9,485 |
Free Cash Flow | -1,770 | -1,173 | -4,887 | -2,594 |
Cash | 4,413 | 4,813 | 6,249 | 7,536 |
Basic Shares | 62,806 | 62,738 | 62,804 | 62,753 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $37,063 | $35,595 | $31,084 | $34,688 |
Gross Profit | 26,491 | 24,887 | 21,953 | 20,733 |
EBITDA | -4,356 | -19,267 | -27,879 | -30,003 |
EBIT | -5,987 | -21,011 | -29,902 | -30,885 |
Net Income | -8,198 | -20,718 | -29,246 | -32,812 |
Net Change In Cash | 37,063 | 35,595 | 31,084 | 34,688 |
Cost of Revenue | -29,730 | |||
Free Cash Flow | -12,541 | -14,712 | -22,591 | -34,689 |
Cash | 6,249 | 3,279 | 14,131 | 22,144 |
Basic Shares | 62,231 | 54,434 | 44,656 | 43,573 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.07 |
2026-03-31 | -$0.08 |
2025-12-31 | -$0.09 |
2025-09-30 | -$0.05 |